Pegcetacoplan
APL2-C3G-204
Phase 3 small_molecule active
Quick answer
Pegcetacoplan for C3G is a Phase 3 program (small_molecule) at Apellis Europe B.V. with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Apellis Europe B.V.
- Indication
- C3G
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active